期刊文献+

纳豆芽孢杆菌产VK_2菌株的NTG与N^+注入复合诱变选育 被引量:4

Mutagenesis by NTG and N^+ implantation for breeding of Bacillus natto producing vitamin K_2
下载PDF
导出
摘要 以纳豆芽孢杆菌BN_2-6为出发菌株,利用亚硝基胍(NTG)和N^+注入复合诱变选育产维生素K_2的突变株。经过NTG诱变后得到突变株BN-N30-1,其维生素K2的产量提高了53%,继而采用低能N^+注入技术进行处理得到突变株BN-P15-11-1,维生素K_2的产量比BN-N30-1提高了96%,比原始菌株提高了166%。结果表明,对纳豆芽孢杆茵BN-2-6进行NTG和低能N^+注入复合诱变的效果明显,突变菌株维生素K_2的产量显著提高。 Using Bacillus natto as the original strain, the combined mutation including N-methyl-N-nitro-N-nitroso- guanidine (NTG) and N+ implantation were conducted to obtain vitamin K2 producing mutants. After the NTG mutation, a mutant strain named BN-N30-1 was obtained and its yield of vitamin K2 increased by 53%, if compared with that of the original strain BN-2-6. Then the mutant strain was further mutated by N+ implantation. As a result, the mutant strain named BN-P15-11-1 was obtained and its vitamin K2 yield increased by 96% over that of the strain BN-N30-1 and by 166% over that of the original strain BN-2-6, respectively. The results showed that the NTG and N+ implantation mutations were effective methods for breeding Bacillus natto and the enhancement of vitamin K2 production was obvious.
出处 《工业微生物》 CAS CSCD 2014年第2期52-56,共5页 Industrial Microbiology
基金 中国科学院知识创新工程青年人才领域前项目(Y09FCQ5121)
关键词 纳豆芽孢杆菌 NTG N+注入 维生素K2 Bacillus natto NTG N+ implantation vitamin K2
  • 相关文献

参考文献15

  • 1郭洪敏,杜靖远.维生素K_2对成骨细胞增殖和分化的影响[J].中华老年医学杂志,1998,17(2):73-75. 被引量:16
  • 2Yamaguchi M, Ma ZJ. Inhibitory effect of menaquinone-7 ( vitamin K2 )on osteoclast-like cell formation and ostcoclastic bone resorp- tion in rat bone tissues in vitro[J]. Mol Cell Biochem,2001,228 (1-2) :39-47.
  • 3Takeuehi Y,Suzawa M, Fukumoto S,ec al. Vitamin K2 inhibits adipogenesis, osteoclastogcnesis in human bone narrow cell cul- ture [J]. J Endoerinol,2003,76(3 ) :339 - 348.
  • 4Iwamoto J, Takeda T, Sato Y. Menatetrenone ( vitamin K2 ) and bone quality in the treatment of postmenopausal osteoporosis[ J]. Nutr Rev,2006,64(12) :509-517.
  • 5Gast GCM, Roos NM, Bobs ML, et al. A high menaquinone intake reduces the incidence of coronary heart disease[ J]. Nutr Metab Cardiovas Dis,2009,19 ( 7 ) : 504 -510.
  • 6邹志强 ,符诗聪 ,刘忠厚 .维生素K2的研究进展[J].中国骨质疏松杂志,2005,11(3):389-392. 被引量:31
  • 7Sato T, Yamada Y, Ohtani Y, et al. Efficient production of mena- quinone (vitamin K2 ) by a menadione-resistant mutant of Bacil- lus subtilis [ J ]. J Ind Microbiol Biotechnol, 2001,26 ( 3 ) : 115- 120.
  • 8Berenjian A, Mahanama R, Talbot A, et al. Efficient media for high menaquinone-7 production: response surface methodology approach[J]. New Biotechnol,2011,28(6) : 665-672 .
  • 9Yu ZL,Yu LD,Brown I,et al. Introduction to ion beam biotech- nology[ M ]. Springer, New York,2006.
  • 10Feng HY,Yu ZL,Chu P. Ion implantation of organisms[J]. Ma- ter Sci Eng R,2006,54(3-4) :49-120 .

二级参考文献24

  • 1王洪复,上海医科大学学报,1991年,18卷,475页
  • 2细井孝之.骨粗鬆症の予防と治療にぉけるピタミンK2の)新しい意羲.1996,4:201-2081.
  • 3Ichihashi T, Takagishi Y, allchida, et al, Detection and measurement of vitamins kl and k2 in human cortical and trabecular bone. J Bone Miner Res, 1993,8:1005-1008.
  • 4腰原康子.骨形成,in vitro石( )化にぉけるピタミンK2の)作用機序.Osteoporosis Japan 1996,4(2):191-200.
  • 5原久仁子.ビタミンK2(メナテトレノン)の骨代谢改善作用とその特異性.Osteoporosis Japan,1996,4(2):173-182.
  • 6Ducy P, et al. Nature,1996,3824:48-52.
  • 7Koshihara Y, Hoshi K, et al. Vitamin K2 ( menatetrenone ) inhibits prostaglandin synthesis in cultured human osteo-like periosteal cells by inhibiting prostaglandin H synthase activity. Biochem Pharmacol,1993,19,46:1355-1362.
  • 8村上雅人,岩元一朗,古谢将一郎,等.閉轻前后のNOぉよび骨吸收性サイトカィンに对するビタミンkの影響.OsteoporosisJapan,2001,9:177-178.
  • 9Hiruma Y, Nakahamak, Fujitah, Moritai Vitamin K2 and gerany lageranid, its side chain component, inhibited osteoclast formation inadifferent manner Biochem. Biophys Rescommun ( USA), 2004,314:24-30.
  • 10久米川正好.In vttroにぉけるビタミンK2の骨吸收抑制作用. Osteoporosis Japan, 1996,4:183-190.

共引文献44

同被引文献26

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部